Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

Thryv Therapeutics

Thryv Therapeutics is a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.
2019
11-50
Laval, Quebec, Canada

Investment Funding

Last Funding Stage

Convertible Note

Total Funding Amount

40.38M

Last Funding Amount

5.M

Last Funding Date

06-06-2023

Lead Investors

Fonds de solidarité FTQ, Lumira Ventures, Amplitude Venture Capital, Alexandria Venture Investments, Investissement Quebec

People

Founders

Something missing or incorrect on this page? Help us enrich this information